CN Patent

CN106336411B — Cdk4/6抑制剂帕博西尼高纯度原料药的制备工艺及用途

Assigned to Shanghai Pharmaceutical Group Benxi North Pharmaceutical Co ltd · Expires 2018-03-06 · 8y expired

What this patent protects

本发明公开了一种帕博西尼的盐的精制方法，在制得帕博西尼的盐的精制品后，以该帕博西尼的盐的精制品作为帕博西尼的原料中间体；再通过碱的优化选择来脱盐基以达到制备高纯度的原料药级的帕博西尼。本发明的方法操作简单，不需要柱层析和特殊设备，所得产品收率较高，纯度高，适合应用于工业化生产。

USPTO Abstract

本发明公开了一种帕博西尼的盐的精制方法，在制得帕博西尼的盐的精制品后，以该帕博西尼的盐的精制品作为帕博西尼的原料中间体；再通过碱的优化选择来脱盐基以达到制备高纯度的原料药级的帕博西尼。本发明的方法操作简单，不需要柱层析和特殊设备，所得产品收率较高，纯度高，适合应用于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106336411B
Jurisdiction
CN
Classification
—
Expires
2018-03-06
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pharmaceutical Group Benxi North Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.